NasdaqGM - Delayed Quote USD
Structure Therapeutics Inc. (GPCR)
21.97
+0.18
+(0.83%)
At close: June 3 at 4:00:01 PM EDT
22.50
+0.53
+(2.41%)
After hours: June 3 at 7:54:48 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 11 | 9 |
| Avg. Estimate | -0.37 | -0.4 | -1.11 | -1.89 |
| Low Estimate | -1.02 | -1.13 | -4.14 | -5.65 |
| High Estimate | -0.25 | -0.27 | 1.78 | -1.1 |
| Year Ago EPS | -0.18 | -0.2 | -0.78 | -1.11 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 10 |
| Avg. Estimate | -- | -- | 45.45M | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 500M | -- |
| Year Ago Sales | -- | -- | -- | 45.45M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -100.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.19 | -0.17 | -0.23 |
| EPS Actual | -0.18 | -0.2 | -0.22 | -0.27 |
| Difference | 0.05 | -0.01 | -0.05 | -0.04 |
| Surprise % | 20.00% | -7.14% | -32.33% | -16.94% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.37 | -0.4 | -1.11 | -1.89 |
| 7 Days Ago | -0.37 | -0.4 | -1.11 | -1.89 |
| 30 Days Ago | -0.24 | -0.27 | -0.7 | -1.32 |
| 60 Days Ago | -0.24 | -0.27 | -0.68 | -1.36 |
| 90 Days Ago | -0.24 | -0.27 | -0.68 | -1.36 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 3 | 2 | 1 |
| Up Last 30 Days | 2 | 3 | 2 | 1 |
| Down Last 7 Days | 3 | 3 | 5 | 5 |
| Down Last 30 Days | 3 | 3 | 5 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GPCR | -105.56% | -97.50% | -41.89% | -70.63% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/12/2025 |
| Initiated | Citigroup: Buy | 5/2/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/22/2025 |
| Maintains | Citizens Capital Markets: Market Outperform to Market Outperform | 2/28/2025 |
| Initiated | William Blair: Outperform | 2/28/2025 |
| Initiated | Stifel: Buy | 1/8/2025 |
Related Tickers
MTSR Metsera, Inc.
29.35
+4.37%
TERN Terns Pharmaceuticals, Inc.
3.4950
+6.55%
CYTK Cytokinetics, Incorporated
32.00
+2.53%
ALT Altimmune, Inc.
5.42
+2.26%
VKTX Viking Therapeutics, Inc.
26.61
+1.88%
MGX Metagenomi, Inc.
1.7700
+0.57%
MLTX MoonLake Immunotherapeutics
48.55
+17.95%
AKRO Akero Therapeutics, Inc.
51.61
+1.73%
PRTA Prothena Corporation plc
4.8300
+3.65%
BBIO BridgeBio Pharma, Inc.
37.52
+5.81%